Detection of siRNA-mediated target mRNA cleavage activities in human cells by a novel stem-loop array RT-PCR analysis

por Lin, Jing, Xu, Kai, Roth, Jack A., Ji, Lin
Publicado 2016

NPRL2 Sensitizes Human Non-Small Cell Lung Cancer (NSCLC) Cells to Cisplatin Treatment by Regulating Key Components in the DNA Repair Pathway

por Jayachandran, Gitanjali, Ueda, Kentaro, Wang, Bingbing, Roth, Jack A., Ji, Lin
Publicado 2010

EGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damage

por Kuroda, Shinji, Tam, Justina, Roth, Jack A, Sokolov, Konstantin, Ramesh, Rajagopal
Publicado 2014

MicroRNA-mediated target mRNA cleavage and 3′-uridylation in human cells

por Xu, Kai, Lin, Jing, Zandi, Roza, Roth, Jack A., Ji, Lin
Publicado 2016

Apoptosis Induction by MEK Inhibition in Human Lung Cancer Cells Is Mediated by Bim

por Meng, Jieru, Fang, Bingliang, Liao, Yong, Chresta, Christine M., Smith, Paul D., Roth, Jack A.
Publicado 2010

CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenografts

por Huang, Licai, Wang, Jing, Fang, Bingliang, Meric-Bernstam, Funda, Roth, Jack A., Ha, Min Jin
Publicado 2022

Tumor Suppressor Gene-Based Nanotherapy: From Test Tube to the Clinic

por Shanker, Manish, Jin, Jiankang, Branch, Cynthia D., Miyamoto, Shinya, Grimm, Elizabeth A., Roth, Jack A., Ramesh, Rajagopal
Publicado 2011

Genetic Variations in the Regulator of G-Protein Signaling Genes Are Associated with Survival in Late-Stage Non-Small Cell Lung Cancer

por Dai, Jingyao, Gu, Jian, Lu, Charles, Lin, Jie, Stewart, David, Chang, David, Roth, Jack A., Wu, Xifeng
Publicado 2011

The Tumor Suppressor Gene TUSC2 (FUS1) Sensitizes NSCLC to the AKT Inhibitor MK2206 in LKB1-dependent Manner

por Meng, Jieru, Majidi, Mourad, Fang, Bingliang, Ji, Lin, Bekele, B. Nebiyou, Minna, John D., Roth, Jack A.
Publicado 2013

Different dietary patterns and reduction of lung cancer risk: A large case-control study in the U.S.

por Tu, Huakang, Heymach, John V., Wen, Chi-Pang, Ye, Yuanqing, Pierzynski, Jeanne A., Roth, Jack A., Wu, Xifeng
Publicado 2016

Genetic associations of T cell cancer immune response-related genes with T cell phenotypes and clinical outcomes of early-stage lung cancer

por Wang, Qinchuan, Gu, Jianchun, Wang, Linbo, Chang, David W, Ye, Yuanqing, Huang, Maosheng, Roth, Jack A, Wu, Xifeng
Publicado 2020

TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model

por Meraz, Ismail M., Majidi, Mourad, Shao, RuPing, Meng, Feng, Ha, Min Jin, Shpall, Elizabeth, Roth, Jack A.
Publicado 2022

In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection

por Gjetting, Torben, Arildsen, Nicolai Skovbjerg, Christensen, Camilla Laulund, Poulsen, Thomas Tuxen, Roth, Jack A, Handlos, Vagn Neerup, Poulsen, Hans Skovgaard
Publicado 2010

MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non–Small Cell Lung Cancer

por Li, Rong, Pu, Xia, Chang, Joe Y., Ye, Yuanqing, Komaki, Ritsuko, Minna, John D., Roth, Jack A., Han, Baohui, Wu, Xifeng
Publicado 2016

Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy

por Pataer, Apar, Shao, Ruping, Correa, Arlene M., Behrens, Carmen, Roth, Jack A., Vaporciyan, Ara A., Wistuba, Ignacio I., Swisher, Stephen G.
Publicado 2018

Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer

por Chang, Joe Y, Liu, Hui, Balter, Peter, Komaki, Ritsuko, Liao, Zhongxing, Welsh, James, Mehran, Reza J, Roth, Jack A, Swisher, Stephen G
Publicado 2012

Genetic variation in the TNF/TRAF2/ASK1/p38 kinase signaling pathway as markers for postoperative pulmonary complications in lung cancer patients

por Hildebrandt, Michelle A. T., Roth, Jack A., Vaporciyan, Ara A., Pu, Xia, Ye, Yuanqing, Correa, Arlene M., Kim, Jae Y., Swisher, Stephen G., Wu, Xifeng
Publicado 2015

Predictors for Locoregional Recurrence for Clinical Stage III-N2 Non-small Cell Lung Cancer with Nodal Downstaging After Induction Chemotherapy and Surgery

por Amini, Arya, Lou, Feiran, Correa, Arlene M., Baldassarre, Randall, Rimner, Andreas, Huang, James, Roth, Jack A., Swisher, Stephen G., Vaporciyan, Ara A., Lin, Steven H.
Publicado 2012

TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin

por Xiaobo, Cao, Majidi, Mourad, Feng, Meng, Shao, Ruping, Wang, Jing, Zhao, Yang, Baladandayuthapani, Veerabhadran, Song, Juhee, Fang, Bingliang, Ji, Lin, Mehran, Reza, Roth, Jack A.
Publicado 2016

TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC)

por Cao, Xiaobo, Zhao, Yang, Wang, Jing, Dai, Bingbing, Gentile, Emanuela, Lin, Jing, Pu, Xingxiang, Ji, Lin, Wu, Shuhong, Meraz, Ismail, Majidi, Mourad, Roth, Jack A.
Publicado 2017